ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

10.26
0.12
(1.18%)
Closed 21 January 8:00AM
10.26
-0.01
(-0.10%)
After Hours: 10:37AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
10.26
Bid
5.88
Offer
12.30
Volume
272,127
10.17 Day's Range 10.52
9.5005 52 Week Range 30.1886
Market Cap
Previous Close
10.14
Open
10.28
Last Trade Time
Financial Volume
US$ 2,812,162
VWAP
10.334
Average Volume (3m)
557,793
Shares Outstanding
58,227,593
Dividend Yield
-
PE Ratio
-3.90
Earnings Per Share (EPS)
-2.63
Revenue
-
Net Profit
-153.16M

About Cullinan Therapeutics Inc

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was US$10.14. Over the last year, Cullinan Therapeutics shares have traded in a share price range of US$ 9.5005 to US$ 30.1886.

Cullinan Therapeutics currently has 58,227,593 shares in issue. The market capitalisation of Cullinan Therapeutics is US$590.43 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -3.90.

CGEM Latest News

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.72-6.5573770491810.9811.319.500579798810.60264602CS
4-0.56-5.1756007393710.8212.9859.500564898211.52347009CS
12-5.63-35.431088735115.8917.50349.500555779313.07104175CS
26-8.1-44.117647058818.3621.019.500557519415.73552799CS
52-0.02-0.19455252918310.2830.18869.500565207718.10796486CS
156-3.08-23.088455772113.3430.18867.338529815.07857137CS
260-31.74-75.57142857144259.857.335534217.75262173CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?
The current share price of Cullinan Therapeutics is US$ 10.26
How many Cullinan Therapeutics shares are in issue?
Cullinan Therapeutics has 58,227,593 shares in issue
What is the market cap of Cullinan Therapeutics?
The market capitalisation of Cullinan Therapeutics is USD 590.43M
What is the 1 year trading range for Cullinan Therapeutics share price?
Cullinan Therapeutics has traded in the range of US$ 9.5005 to US$ 30.1886 during the past year
What is the PE ratio of Cullinan Therapeutics?
The price to earnings ratio of Cullinan Therapeutics is -3.9
What is the reporting currency for Cullinan Therapeutics?
Cullinan Therapeutics reports financial results in USD
What is the latest annual profit for Cullinan Therapeutics?
The latest annual profit of Cullinan Therapeutics is USD -153.16M
What is the registered address of Cullinan Therapeutics?
The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cullinan Therapeutics website address?
The website address for Cullinan Therapeutics is www.cullinantherapeutics.com
Which industry sector does Cullinan Therapeutics operate in?
Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

Your Recent History

Delayed Upgrade Clock